Otsuka Pharmaceuticals Implements Antibody Discovery, and Cell & Gene Therapy Research & Development by Utilizing the Berkeley Lights Beacon(R) Platform
By asianet
Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Otsuka Pharmaceuticals, a leading pharmaceutical company, has implemented the use of the Berkeley Lights Beacon(R) system for antibody discovery, as well as cell and gene therapy and cell line development research. Logo – https://mma.prnewswire.com/media/1078159/Berkeley_Lights_Logo.jpg Since acquiring the Beacon Platform in October 2021, … Continued